Safety and toxicity of cabozantinib monotherapy in patients with advanced renal cell carcinoma: a Russian multicenter observational study

Safety and toxicity of cabozantinib monotherapy in patients with advanced renal cell carcinoma: a Russian multicenter observational study

Aim. To assess the safety and to analyze an influence of cabozantinib monotherapy toxicity on treatment efficacy in unselected Russian patients with metastatic renal cell carcinoma (mRCC). Materials and methods. Medical data of 92 patients with verified mRCC were included in the study. The median...

Full description

Bibliographic Details
Main Authors: Maria I. Volkova, Alexey S. Kalpinskiy, Konstantin V. Menshikov, Lilia V. Gorbuleva, Alexander V. Sultanbaev, Olga I. Evsyukova, Varazdat R. Meltonian, Sergey V. Mishugin, Mikhail R. Maturov, Anna S. Olshanskaya, Dmitrii Iu. Shemetov, Tatyana A. Sannikova, Mariia V. Makhnutina, Marina A. Filipieva, Elena A. Gaijsina, Elena G. Ovchinnikova, Ovsep A. Mailian, Boris Ya. Alekseev, Vsevolod B. Matveev
Format: Article
Language:Russian
Published: IP Habib O.N. 2023-08-01
Series:Современная онкология
Subjects:
renal cell carcinoma
cabozantinib
safety
toxicity, hypertension
Online Access:https://modernonco.orscience.ru/1815-1434/article/viewFile/456802/pdf

Internet

https://modernonco.orscience.ru/1815-1434/article/viewFile/456802/pdf

Similar Items